| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | +3.3% | +127.8% |
| Cost of Revenue | $2.1M | +31.9% | +12.4% |
| Gross Profit | -$298K | -291.0% | +72.5% |
| R&D Expense | $2.5M | -20.6% | -46.6% |
| SG&A Expense | $4.9M | +4.8% | -31.4% |
| Operating Income | -$7.7M | -0.6% | +40.3% |
| Pre-tax Income | -$8.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.7M | +94.9% | -65.9% |
| Short-term Investments | $996K | -33.0% | — |
| Accounts Receivable | $892K | +10.9% | +60.4% |
| Inventory | $2.2M | -8.4% | -11.8% |
| Current Assets | $18.6M | +24.0% | -51.1% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | -98.4% | — |
| Capital Expenditures | $444K | +124.2% | — |
| Investing Cash Flow | $816K | +41.7% | — |
| Financing Cash Flow | $13.0M | +219.3% | — |
| Free Cash Flow | -$9.4M | -99.5% | — |
| -2.2% |
| +41.1% |
| Net Income | -$7.9M | -3.2% | +40.6% |
| EPS (Basic) | -$1.25 | +18.3% | -346.4% |
| EPS (Diluted) | -$1.25 | +18.3% | -346.4% |
| $31.0M |
| +10.1% |
| -41.6% |
| Current Liabilities | $4.4M | -5.3% | -33.6% |
| Total Liabilities | $17.9M | +0.9% | -24.7% |
| Stockholders' Equity | $12.7M | +28.3% | -54.7% |